Melinda Magyari was born in Transylvania.She did her undergraduate medical training at the Semmelweis University in Budapest. She moved to Denmark and graduated in medicine at University of Southern Denmark in 1999. After completing her specialist training in neurology in 2008 she obtained PhD degree at University of Copenhagen in 2014.
Currently she is the director of The Danish Multiple Sclerosis Registry, a consultant neurologist at the Danish Multiple Sclerosis Center, Department of Neurology Rigshospitalet and Associate Professor at Copenhagen University Hospital, Rigshospitalet, Denmark.
Dr. Magyari’s Melinda Magyari’s major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in gender differences.
During the past years, Melinda Magyari has been involved in epidemiological studies addressing questions regarding reproductive issues and risk factors in multiple sclerosis. Her current research is focused on observational studies investigating the effectiveness, safety and social consequences of disease modifying therapies using data from registries. Furthermore, she is engaged in a multi-center treatment trial investigating new ways of monitoring major depressive disorders, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.
She is strongly involved in international collaborations with other multiple sclerosis databases and is a member of the BIG MS steering committee
She has authored more than 60 articles indexed on PubMed and has supervised several undergraduate and Ph. D students. She is a member of several national and international scientific committees and a fellow of the European Academy of Neurology.